Skip to main content

Advertisement

SpringerLink
Log in

Platelet-rich plasma inhibits inflammatory factors and represses rheumatoid fibroblast-like synoviocytes in rheumatoid arthritis

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is a chronic disease affecting daily life of numerous patients, and uncontrolled proliferation of synovial fibroblasts plays vital role during the pathology of RA. Platelet-rich plasma (PRP), widely used in tissue regeneration and pain management, is rarely studied in RA. This study aims to investigate the effect of PRP on synovial fibroblasts during RA. Rheumatoid fibroblast-like synoviocyte MH7A cells were stimulated by lipopolysaccharide (LPS) to simulate RA conditions and treated with PRP, after that the concentration of inflammatory factors interleukin (IL) 1β, tumor necrosis factor alpha (TNFα) and IL6 in the supernatant of culture medium was quantified by ELISA. MTT assay, flow cytometry and tube formation assay were performed to assess changes in cell viability, apoptosis and effect on angiogenesis in vitro, respectively. Besides, the expression levels of main factors in the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signal pathway were examined. Results showed that PRP markedly inhibited the production of IL1β, TNFα and IL6 (P < 0.05) that was stimulated by LPS. LPS promoted MH7A cell viability, inhibited apoptosis and accelerated angiogenesis in vitro, while PRP could markedly relieve these effects (P < 0.05). The mRNA and protein levels of AKT1, PI3K (p58) and nuclear factor κ beta were elevated by LPS and then suppressed by PRP (P < 0.01). This study uncovered the potential of PRP in inhibiting inflammation, repressing synovial fibroblasts and regulating the PI3K/AKT signaling, providing basic proof for future application of PRP in managing RA. Further investigation is necessary to reveal detailed mechanism of PRP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Costenbader KH, Chang SC, Laden F, Puett R, Karlson EW. Geographic variation in rheumatoid arthritis incidence among women in the United States. Archives of Internal Medicine. 2008;168(15):1664–70.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–108.

    Article  PubMed  Google Scholar 

  3. Kallberg H, Ding B, Padyukov L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Annals of the Rheumatic Diseases. 2011;70(3):508–11. doi:10.1136/ard.2009.120899.

    Article  PubMed  Google Scholar 

  4. Kato K, Segami N, Fukuda H, Minato H. Rheumatoid nodule in the lower lip of a patient with rheumatoid arthritis: a novel case report and review of literature. Journal of Oral and Maxillofacial Surgery. 2014;72(8):1532.e1–5.

    Article  Google Scholar 

  5. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis and Rheumatism. 2010;62(6):1583–91.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ozbalkan Z, Efe C, Cesur M, et al. An update on the relationships between rheumatoid arthritis and atherosclerosis. Atherosclerosis. 2010;212(2):377–82.

    Article  CAS  PubMed  Google Scholar 

  7. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. New England Journal of Medicine. 1997;337(3):141–7.

    Article  CAS  PubMed  Google Scholar 

  8. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. New England Journal of Medicine. 2011;365(23):2205–19.

    Article  CAS  PubMed  Google Scholar 

  9. Zhai Y, Wu B, Li J, Yao XY, Zhu P, Chen ZN. CD147 promotes IKK/IκB/NF-κB pathway to resist TNF-induced apoptosis in rheumatoid arthritis synovial fibroblasts. J Mol Med (Berl). 2016;94(1):71–82.

    Article  CAS  Google Scholar 

  10. Chen Y, Dawes PT, Mattey DL. Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: differential effect of cigarette smoking. Cytokine. 2012;58(3):390–7.

    Article  CAS  PubMed  Google Scholar 

  11. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. American Journal of Sports Medicine. 2009;37(11):2259–72. doi:10.1177/0363546509349921.

    Article  PubMed  Google Scholar 

  12. Kaux JF, Crielaard JM. Platelet-rich plasma application in the management of chronic tendinopathies. Acta Orthopaedica Belgica. 2013;79(1):10–5.

    PubMed  Google Scholar 

  13. Zhu X, Zhang C, Huang GT, Cheung GS, Dissanayaka WL, Zhu W. Transplantation of dental pulp stem cells and platelet-rich plasma for pulp regeneration. J Endod. 2012;38(12):1604–9.

    Article  PubMed  Google Scholar 

  14. Knezevic NN, Candido KD, Desai R, Kaye AD. Is platelet-rich plasma a future therapy in pain management? Medical Clinics of North America. 2016;100(1):199–217.

    Article  PubMed  Google Scholar 

  15. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2011;19(4):528–35.

    Article  PubMed  Google Scholar 

  16. Jang SJ, Kim JD, Cha SS. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. European Journal of Orthopaedic Surgery & Traumatology. 2013;23(5):573–80.

    Article  Google Scholar 

  17. Kon E, Filardo G, Di MB, Marcacci M. PRP for the treatment of cartilage pathology. Open Orthopaed J. 2013;7(7):120–8.

    Article  Google Scholar 

  18. Osterman C, McCarthy MB, Cote MP, et al. Platelet-rich plasma increases anti-inflammatory markers in a human coculture model for osteoarthritis. American Journal of Sports Medicine. 2015;43(6):1474–84. doi:10.1177/0363546515570463.

    Article  PubMed  Google Scholar 

  19. Kang J, Yuan W, Chang Z, Sun H, Yu X. Study of proliferation of chondrocytes co-cultured with platelet rich gel. J Reg Anat Operat Surg. 2015;24(4):387–9 (in Chinese).

    Google Scholar 

  20. Mohammadi E, Vatanpour H, Shirazi FH. Immunomodulatory effects of bee venom in human synovial fibroblast cell line. Iran J Pharm Res. 2015;14(1):313–20.

    PubMed  PubMed Central  Google Scholar 

  21. Zhao G, Zhu Y, Eno CO, et al. Activation of the proapoptotic BCL-2 protein BAX by a small molecule induces tumor cell apoptosis. Molecular and Cellular Biology. 2014;34(7):1198–207. doi:10.1128/mcb.00996-13.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Volkmann N, Marassi FM, Newmeyer DD, Hanein D. The rheostat in the membrane: BCL-2 family proteins and apoptosis. Cell Death and Differentiation. 2014;21(2):206–15. doi:10.1038/cdd.2013.153.

    Article  CAS  PubMed  Google Scholar 

  23. Arany Z, Foo SY, Ma Y, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451(7181):1008–12. doi:10.1038/nature06613.

    Article  CAS  PubMed  Google Scholar 

  24. Oliver SJ, Banquerigo ML, Brahn E. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cellular Immunology. 1994;157(1):291–9.

    Article  CAS  PubMed  Google Scholar 

  25. Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 2011;4:51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Andreassen SM, Berg LC, Nielsen SS, Kristensen AT, Jacobsen S. mRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin. BMC Vet Res. 2015;11:141.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Seong AR, Yoo JY, Choi K, et al. Delphinidin, a specific inhibitor of histone acetyltransferase, suppresses inflammatory signaling via prevention of NF-κB acetylation in fibroblast-like synoviocyte MH7A cells. Biochem Biophys Res Commun. 2011;410(3):581–6.

    Article  CAS  PubMed  Google Scholar 

  28. Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nature Reviews Rheumatology. 2013;9(12):721–30.

    Article  CAS  PubMed  Google Scholar 

  29. Ji H, Huo X, Zhang H, Wang Y, Shi X, Huo L. Platelet-rich plasma with sodium hyaluronate in repair of rabbit knee osteoarthritis. Chin J Tissue Eng Res. 2015;19(38):6133–9.

    CAS  Google Scholar 

  30. Amable PR, Carias RBV, Teixeira MVT, da Cruz Pacheco Í, do Amaral RJFC, Granjeiro JM, Borojevic R. Platelet-rich plasma preparation for regenerative medicine optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(67):13.

    Google Scholar 

  31. Jin XN, Yan EZ, Wang HM, et al. Hyperoside exerts anti-inflammatory and anti-arthritic effects in LPS-stimulated human fibroblast-like synoviocytes in vitro and in mice with collagen-induced arthritis. Acta Pharmacologica Sinica. 2016;37(5):674–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Rezende MUD, Silva RBBD, Bassit ACF, Tatsui NH, Sadigursky D, Neto RB. Effect of platelet-rich plasma on impact-induced chondrocyte apoptosis. Acta Ortop Bras. 2011;19(2):102–5.

    Article  Google Scholar 

  33. Drengk A, Zapf A, Stürmer EK, Stürmer KM, Frosch KH. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs. 2009;189(5):317–26.

    Article  PubMed  Google Scholar 

  34. Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ, Kusumoto K. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plastic and Reconstructive Surgery. 2008;122(5):1352–60.

    Article  CAS  PubMed  Google Scholar 

  35. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. Journal of Biological Chemistry. 2000;275(1):444–50.

    Article  CAS  PubMed  Google Scholar 

  36. Reitamo S, Remitz A, Tamai K, Uitto J. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Investig. 1995;94(6):2489–92.

    Article  Google Scholar 

  37. Lippross S, Moeller B, Haas H, et al. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis and Rheumatism. 2011;63(11):3344–53. doi:10.1002/art.30547.

    Article  CAS  PubMed  Google Scholar 

  38. Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. American Journal of Sports Medicine. 2014;42(5):1204–10.

    Article  PubMed  Google Scholar 

  39. Lyras DN, Kazakos K, Verettas D, et al. The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot and Ankle International. 2009;30(11):1101–6.

    Article  PubMed  Google Scholar 

  40. Browning SR, Weiser AM, Woolf N, et al. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. Journal of Bone and Joint Surgery. American Volume. 2012;94(23):e1721–7. doi:10.2106/JBJS.K.01501.

    Article  Google Scholar 

  41. Wang J, Zhang W, Zou H, et al. 10-Hydroxy-2-decenoic acid inhibiting the proliferation of fibroblast-like synoviocytes by PI3K-AKT pathway. International Immunopharmacology. 2015;28(1):97–104.

    Article  PubMed  Google Scholar 

  42. Hsieh CJ, Hall K, Ha T, Li C, Krishnaswamy G, Chi DS. Baicalein inhibits IL-1β- and TNF-α-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathway. Clin Mol Allergy. 2007;5:5.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Orthopaedics, Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, No. 600, Yishan Road, Shanghai, China

    Shichao Tong & Changqing Zhang

  2. Department of Orthopaedics, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

    Ji Liu

Authors
  1. Shichao Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ji Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Changqing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Changqing Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tong, S., Liu, J. & Zhang, C. Platelet-rich plasma inhibits inflammatory factors and represses rheumatoid fibroblast-like synoviocytes in rheumatoid arthritis. Clin Exp Med 17, 441–449 (2017). https://doi.org/10.1007/s10238-017-0449-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-017-0449-2

Keywords

Search

Navigation